Based on loss of expression in human HNSCC and cellular effects associated with loss of LZAP such as enhanced invasion, anchorage independent growth, angiogenesis, and growth of xenograft tumors, LZAP has been identified as a putative tumor suppressor [3]. Here, CDK5RAP3 is linked to head and neck squamous cell carcinoma.